TY - JOUR AU - Acquaye, C. AU - Blanchette-Mackie, E. J. AU - Reindorf, C. AU - Edelstein, S. AU - Schechter, A. N. PY - 1988 DA - 1988// TI - Electron microscopic studies of the intracellular polymerization of sickle hemoglobin JO - Blood Cells VL - 13 ID - Acquaye1988 ER - TY - JOUR AU - Aguilar-Lopez, L. B. AU - Delgado-Lamas, J. L. AU - Rubio-Jurado, B. AU - Perea, F. J. AU - Ibarra, B. PY - 2008 DA - 2008// TI - Thalidomide therapy in a patient with thalassemia major JO - Blood Cells Mol Dis VL - 41 UR - https://doi.org/10.1016/j.bcmd.2008.03.001 DO - 10.1016/j.bcmd.2008.03.001 ID - Aguilar-Lopez2008 ER - TY - JOUR AU - Aljurf, M. PY - 1996 DA - 1996// TI - Abnormal assembly of membrane proteins in erythroid progenitors of patients with beta-thalassemia major JO - Blood VL - 87 ID - Aljurf1996 ER - TY - JOUR AU - An, X. AU - Schulz, V. P. AU - Mohandas, N. AU - Gallagher, P. G. PY - 2015 DA - 2015// TI - Human and murine erythropoiesis JO - Curr Opin Hematol VL - 22 UR - https://doi.org/10.1097/MOH.0000000000000134 DO - 10.1097/MOH.0000000000000134 ID - An2015 ER - TY - JOUR AU - Andersen, C. L. PY - 2014 DA - 2014// TI - A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2013.096669 DO - 10.3324/haematol.2013.096669 ID - Andersen2014 ER - TY - JOUR AU - Angelucci, E. PY - 2014 DA - 2014// TI - Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2013.099747 DO - 10.3324/haematol.2013.099747 ID - Angelucci2014 ER - TY - JOUR AU - Archer, N. AU - Galacteros, F. AU - Brugnara, C. PY - 2015 DA - 2015// TI - 2015 Clinical trials update in sickle cell anemia JO - Am J Hematol VL - 90 UR - https://doi.org/10.1002/ajh.24116 DO - 10.1002/ajh.24116 ID - Archer2015 ER - TY - JOUR AU - Atweh, G. F. PY - 1999 DA - 1999// TI - Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease JO - Blood VL - 93 ID - Atweh1999 ER - TY - JOUR AU - Aydinok, Y. PY - 2016 DA - 2016// TI - Efficacy and safety of Ruxolitinib in regularly transfused patients with thalassemia: results from single-arm, multicenter, phase 2a Truth study JO - Blood VL - 128 UR - https://doi.org/10.1182/blood-2016-01-690727 DO - 10.1182/blood-2016-01-690727 ID - Aydinok2016 ER - TY - JOUR AU - Babitt, J. L. PY - 2006 DA - 2006// TI - Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression JO - Nat Genet VL - 38 UR - https://doi.org/10.1038/ng1777 DO - 10.1038/ng1777 ID - Babitt2006 ER - TY - JOUR AU - Bacigalupo, A. PY - 2012 DA - 2012// TI - Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation? JO - Hematology Am Soc Hematol Educ Program VL - 2012 ID - Bacigalupo2012 ER - TY - JOUR AU - Baxter, E. J. PY - 2005 DA - 2005// TI - Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders JO - Lancet (London, England) VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)74230-6 DO - 10.1016/S0140-6736(05)74230-6 ID - Baxter2005 ER - TY - JOUR AU - Bessis, M. PY - 1958 DA - 1958// TI - Erythroblastic island, functional unity of bone marrow JO - Revue d'hematologie VL - 13 ID - Bessis1958 ER - TY - JOUR AU - Bessis, M. AU - Mize, C. AU - Prenant, M. PY - 1978 DA - 1978// TI - Erythropoiesis: comparison of in vivo and in vitro amplification JO - Blood Cells VL - 4 ID - Bessis1978 ER - TY - JOUR AU - Bessis, M. C. AU - Breton-Gorius, J. PY - 1962 DA - 1962// TI - Iron metabolism in the bone marrow as seen by electron microscopy: a critical review JO - Blood VL - 19 ID - Bessis1962 ER - TY - JOUR AU - Boutou, A. K. PY - 2012 DA - 2012// TI - Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study JO - QJM VL - 105 UR - https://doi.org/10.1093/qjmed/hcs024 DO - 10.1093/qjmed/hcs024 ID - Boutou2012 ER - TY - JOUR AU - Brawley, O. W. PY - 2008 DA - 2008// TI - National Institutes of Health consensus development conference statement: hydroxyurea treatment for sickle cell disease JO - Ann Intern Med VL - 148 UR - https://doi.org/10.7326/0003-4819-148-12-200806170-00220 DO - 10.7326/0003-4819-148-12-200806170-00220 ID - Brawley2008 ER - TY - JOUR AU - Broxmeyer, H. E. PY - 2013 DA - 2013// TI - Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration JO - J Exp Med VL - 210 UR - https://doi.org/10.1084/jem.20122760 DO - 10.1084/jem.20122760 ID - Broxmeyer2013 ER - TY - JOUR AU - Bunn, H. F. PY - 2013 DA - 2013// TI - Erythropoietin JO - Cold Spring Harb Perspect Med VL - 3 UR - https://doi.org/10.1101/cshperspect.a011619 DO - 10.1101/cshperspect.a011619 ID - Bunn2013 ER - TY - JOUR AU - Carrancio, S. PY - 2014 DA - 2014// TI - An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin JO - Br J Haematol VL - 165 UR - https://doi.org/10.1111/bjh.12838 DO - 10.1111/bjh.12838 ID - Carrancio2014 ER - TY - JOUR AU - Casu, C. PY - 2011 DA - 2011// TI - Potential therapeutic applications of Jak2 inhibitors in Beta-thalassemia and sickle cell disease JO - Blood VL - 118 ID - Casu2011 ER - TY - JOUR AU - Casu, C. PY - 2016 DA - 2016// TI - Potential therapeutic applications of Jak2 inhibitors and Hif2a-ASO for the treatment of β-thalassemia intermedia and major JO - Blood VL - 128 UR - https://doi.org/10.1182/blood-2015-10-676742 DO - 10.1182/blood-2015-10-676742 ID - Casu2016 ER - TY - JOUR AU - Casu, C. PY - 2016 DA - 2016// TI - Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia JO - Haematologica VL - 101 UR - https://doi.org/10.3324/haematol.2015.133348 DO - 10.3324/haematol.2015.133348 ID - Casu2016 ER - TY - JOUR AU - Cavazzana, M. PY - 2017 DA - 2017// TI - Longer term follow-up on the first patients with severe Hemoglobinopathies treated with Lentiglobin gene therapy JO - Blood VL - 130 ID - Cavazzana2017 ER - TY - JOUR AU - Cavazzana-Calvo, M. PY - 2010 DA - 2010// TI - Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia JO - Nature VL - 467 UR - https://doi.org/10.1038/nature09328 DO - 10.1038/nature09328 ID - Cavazzana-Calvo2010 ER - TY - JOUR AU - Centis, F. PY - 2000 DA - 2000// TI - The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major JO - Blood VL - 96 ID - Centis2000 ER - TY - JOUR AU - Chandrakasan, S. AU - Malik, P. PY - 2014 DA - 2014// TI - Gene therapy for hemoglobinopathies: the state of the field and the future JO - Hematol Oncol Clin North Am VL - 28 UR - https://doi.org/10.1016/j.hoc.2013.12.003 DO - 10.1016/j.hoc.2013.12.003 ID - Chandrakasan2014 ER - TY - JOUR AU - Chang, C. J. AU - Bouhassira, E. E. PY - 2012 DA - 2012// TI - Zinc-finger nuclease-mediated correction of alpha-thalassemia in iPS cells JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-03-420703 DO - 10.1182/blood-2012-03-420703 ID - Chang2012 ER - TY - JOUR AU - Charache, S. PY - 1983 DA - 1983// TI - Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex JO - Proc Natl Acad Sci U S A VL - 80 UR - https://doi.org/10.1073/pnas.80.15.4842 DO - 10.1073/pnas.80.15.4842 ID - Charache1983 ER - TY - JOUR AU - Crispino, J. D. AU - Weiss, M. J. PY - 2014 DA - 2014// TI - Erythro-megakaryocytic transcription factors associated with hereditary anemia JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2014-01-453167 DO - 10.1182/blood-2014-01-453167 ID - Crispino2014 ER - TY - JOUR AU - Crosby, W. H. PY - 1957 DA - 1957// TI - Siderocytes and the spleen JO - Blood VL - 12 ID - Crosby1957 ER - TY - JOUR AU - Crosby, W. H. PY - 1959 DA - 1959// TI - Normal functions of the spleen relative to red blood cells: a review JO - Blood VL - 14 ID - Crosby1959 ER - TY - JOUR AU - Dai, Y. AU - Chen, T. AU - Ijaz, H. AU - Cho, E. H. AU - Steinberg, M. H. PY - 2017 DA - 2017// TI - SIRT1 activates the expression of fetal hemoglobin genes JO - Am J Hematol VL - 92 UR - https://doi.org/10.1002/ajh.24879 DO - 10.1002/ajh.24879 ID - Dai2017 ER - TY - JOUR AU - De Falco, L. PY - 2010 DA - 2010// TI - Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) JO - Hum Mutat VL - 31 UR - https://doi.org/10.1002/humu.21243 DO - 10.1002/humu.21243 ID - De Falco2010 ER - TY - JOUR AU - De Maria, R. PY - 1999 DA - 1999// TI - Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis JO - Blood VL - 93 ID - De Maria1999 ER - TY - JOUR AU - deDreuzy, E. PY - 2017 DA - 2017// TI - Expanding CRISPR genome editing strategies in hematopoietic stem and progenitor cells for the treatment of hematologic diseases JO - Blood VL - 130 ID - deDreuzy2017 ER - TY - JOUR AU - DeSimone, J. AU - Heller, P. AU - Hall, L. AU - Zwiers, D. PY - 1982 DA - 1982// TI - 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons JO - Proc Natl Acad Sci U S A VL - 79 UR - https://doi.org/10.1073/pnas.79.14.4428 DO - 10.1073/pnas.79.14.4428 ID - DeSimone1982 ER - TY - JOUR AU - Dever, D. P. PY - 2016 DA - 2016// TI - CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells JO - Nature VL - 539 UR - https://doi.org/10.1038/nature20134 DO - 10.1038/nature20134 ID - Dever2016 ER - TY - JOUR AU - Dever, D. P. PY - 2017 DA - 2017// TI - Preclinical development of HBB gene correction in autologous hematopoietic stem and progenitor cells to treat severe sickle cell disease JO - Blood VL - 130 ID - Dever2017 ER - TY - STD TI - Dulmovits BM, et al. Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors. Blood. 2016;127(11):1481-92. https://doi.org/10.1182/blood-2015-09-667923. Epub 2015 Dec 17. PMCID: PMC4797024. ID - ref40 ER - TY - JOUR AU - Dunbar, C. AU - Travis, W. AU - Kan, Y. W. AU - Nienhuis, A. PY - 1989 DA - 1989// TI - 5-Azacytidine treatment in a beta (0)-thalassaemic patient unable to be transfused due to multiple alloantibodies JO - Br J Haematol VL - 72 UR - https://doi.org/10.1111/j.1365-2141.1989.tb07734.x DO - 10.1111/j.1365-2141.1989.tb07734.x ID - Dunbar1989 ER - TY - JOUR AU - Dzierzak, E. AU - Philipsen, S. PY - 2013 DA - 2013// TI - Erythropoiesis: development and differentiation JO - Cold Spring Harb Perspect Med VL - 3 UR - https://doi.org/10.1101/cshperspect.a011601 DO - 10.1101/cshperspect.a011601 ID - Dzierzak2013 ER - TY - JOUR AU - Esrick, E. B. AU - McConkey, M. AU - Lin, K. AU - Frisbee, A. AU - Ebert, B. L. PY - 2015 DA - 2015// TI - Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation JO - Am J Hematol VL - 90 UR - https://doi.org/10.1002/ajh.24019 DO - 10.1002/ajh.24019 ID - Esrick2015 ER - TY - JOUR AU - Fahmy, M. AU - Young, S. P. PY - 1993 DA - 1993// TI - Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA JO - Biochem J VL - 296 UR - https://doi.org/10.1042/bj2960175 DO - 10.1042/bj2960175 ID - Fahmy1993 ER - TY - JOUR AU - Finazzi, G. PY - 2013 DA - 2013// TI - A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy JO - Br J Haematol VL - 161 UR - https://doi.org/10.1111/bjh.12332 DO - 10.1111/bjh.12332 ID - Finazzi2013 ER - TY - JOUR AU - Freireich, E. J. AU - Ross, J. F. AU - Bayles, T. B. AU - Emerson, C. P. AU - Finch, S. C. PY - 1957 DA - 1957// TI - Radioactive iron metabolism and erythrocyte survival studies of the mechanism of the anemia associated with rheumatoid arthritis JO - J Clin Invest VL - 36 UR - https://doi.org/10.1172/JCI103500 DO - 10.1172/JCI103500 ID - Freireich1957 ER - TY - JOUR AU - Geyer, H. PY - 2016 DA - 2016// TI - Symptomatic profiles of patients with polycythemia Vera: implications of inadequately controlled disease JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.62.9337 DO - 10.1200/JCO.2015.62.9337 ID - Geyer2016 ER - TY - JOUR AU - Gifford, S. C. AU - Derganc, J. AU - Shevkoplyas, S. S. AU - Yoshida, T. AU - Bitensky, M. W. PY - 2006 DA - 2006// TI - A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence JO - Br J Haematol VL - 135 UR - https://doi.org/10.1111/j.1365-2141.2006.06279.x DO - 10.1111/j.1365-2141.2006.06279.x ID - Gifford2006 ER - TY - JOUR AU - Gisslinger, H. PY - 2016 DA - 2016// TI - Final results from PROUD-PV a randomized controlled phase 3 trial comparing Ropeginterferon alfa-2b to hydroxyurea in polycythemia Vera patients JO - Blood VL - 128 ID - Gisslinger2016 ER - TY - JOUR AU - Granick, S. AU - Levere, R. D. PY - 1964 DA - 1964// TI - Heme synthesis in erythroid cells JO - Prog Hematol VL - 4 ID - Granick1964 ER - TY - JOUR AU - Grebien, F. PY - 2008 DA - 2008// TI - Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2 JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-07-102848 DO - 10.1182/blood-2007-07-102848 ID - Grebien2008 ER - TY - JOUR AU - Gregory, C. J. AU - Eaves, A. C. PY - 1977 DA - 1977// TI - Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses JO - Blood VL - 49 ID - Gregory1977 ER - TY - JOUR AU - Guo, S. PY - 2013 DA - 2013// TI - Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI66969 DO - 10.1172/JCI66969 ID - Guo2013 ER - TY - JOUR AU - Haberland, M. AU - Montgomery, R. L. AU - Olson, E. N. PY - 2009 DA - 2009// TI - The many roles of histone deacetylases in development and physiology: implications for disease and therapy JO - Nat Rev Genet VL - 10 UR - https://doi.org/10.1038/nrg2485 DO - 10.1038/nrg2485 ID - Haberland2009 ER - TY - JOUR AU - Haigis, M. C. AU - Guarente, L. P. PY - 2006 DA - 2006// TI - Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction JO - Genes Dev VL - 20 UR - https://doi.org/10.1101/gad.1467506 DO - 10.1101/gad.1467506 ID - Haigis2006 ER - TY - JOUR AU - Harteveld, C. L. AU - Higgs, D. R. PY - 2010 DA - 2010// TI - Alpha-thalassaemia JO - Orphanet J Rare Dis VL - 5 UR - https://doi.org/10.1186/1750-1172-5-13 DO - 10.1186/1750-1172-5-13 ID - Harteveld2010 ER - TY - JOUR AU - Hoban, M. D. PY - 2016 DA - 2016// TI - CRISPR/Cas9-mediated correction of the sickle mutation in human CD34+ cells JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.148 DO - 10.1038/mt.2016.148 ID - Hoban2016 ER - TY - JOUR AU - Hockemeyer, D. AU - Jaenisch, R. PY - 2016 DA - 2016// TI - Induced pluripotent stem cells meet genome editing JO - Cell Stem Cell VL - 18 UR - https://doi.org/10.1016/j.stem.2016.04.013 DO - 10.1016/j.stem.2016.04.013 ID - Hockemeyer2016 ER - TY - JOUR AU - Huang, X. PY - 2015 DA - 2015// TI - Production of gene-corrected adult Beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation JO - Stem cells (Dayton, Ohio) VL - 33 UR - https://doi.org/10.1002/stem.1969 DO - 10.1002/stem.1969 ID - Huang2015 ER - TY - JOUR AU - Imagawa, S. AU - Yamamoto, M. AU - Miura, Y. PY - 1997 DA - 1997// TI - Negative regulation of the erythropoietin gene expression by the GATA transcription factors JO - Blood VL - 89 ID - Imagawa1997 ER - TY - JOUR AU - Ingram, V. M. PY - 1956 DA - 1956// TI - A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin JO - Nature VL - 178 UR - https://doi.org/10.1038/178792a0 DO - 10.1038/178792a0 ID - Ingram1956 ER - TY - JOUR AU - James, C. PY - 2005 DA - 2005// TI - A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera JO - Nature VL - 434 UR - https://doi.org/10.1038/nature03546 DO - 10.1038/nature03546 ID - James2005 ER - TY - JOUR AU - Johnson, R. A. AU - Waddelow, T. A. AU - Caro, J. AU - Oliff, A. AU - Roodman, G. D. PY - 1989 DA - 1989// TI - Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice JO - Blood VL - 74 ID - Johnson1989 ER - TY - JOUR AU - Kalantri, S. A. AU - Ray, R. AU - Chattopadhyay, A. AU - Bhattacharyya, M. PY - 2017 DA - 2017// TI - Decitabine as hemoglobin F inducer in hemoglobin E/β thalassemia JO - Blood VL - 130 UR - https://doi.org/10.1182/blood-2017-03-771907 DO - 10.1182/blood-2017-03-771907 ID - Kalantri2017 ER - TY - JOUR AU - Kalfa, T. A. AU - Zheng, Y. PY - 2014 DA - 2014// TI - Rho GTPases in erythroid maturation JO - Curr Opin Hematol VL - 21 UR - https://doi.org/10.1097/MOH.0000000000000032 DO - 10.1097/MOH.0000000000000032 ID - Kalfa2014 ER - TY - JOUR AU - Kan, Y. W. AU - Nathan, D. G. PY - 1970 DA - 1970// TI - Mild thalassemia: the result of interactions of alpha and beta thalassemia genes JO - J Clin Invest VL - 49 UR - https://doi.org/10.1172/JCI106274 DO - 10.1172/JCI106274 ID - Kan1970 ER - TY - JOUR AU - Kan, Y. W. AU - Schwartz, E. AU - Nathan, D. G. PY - 1968 DA - 1968// TI - Globin chain synthesis in the alpha thalassemia syndromes JO - J Clin Invest VL - 47 UR - https://doi.org/10.1172/JCI105933 DO - 10.1172/JCI105933 ID - Kan1968 ER - TY - JOUR AU - Kanter, J. PY - 2017 DA - 2017// TI - Interim results from a phase 1/2 clinical study of Lentiglobin gene therapy for severe sickle cell disease JO - Blood VL - 130 UR - https://doi.org/10.1182/blood-2017-01-764910 DO - 10.1182/blood-2017-01-764910 ID - Kanter2017 ER - TY - JOUR AU - Katsumura, K. R. AU - Bresnick, E. H. PY - 2017 DA - 2017// TI - The GATA factor revolution in hematology JO - Blood VL - 129 UR - https://doi.org/10.1182/blood-2016-09-687871 DO - 10.1182/blood-2016-09-687871 ID - Katsumura2017 ER - TY - JOUR AU - Kautz, L. PY - 2014 DA - 2014// TI - Identification of erythroferrone as an erythroid regulator of iron metabolism JO - Nat Genet VL - 46 UR - https://doi.org/10.1038/ng.2996 DO - 10.1038/ng.2996 ID - Kautz2014 ER - TY - JOUR AU - Kautz, L. PY - 2015 DA - 2015// TI - Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-07-658419 DO - 10.1182/blood-2015-07-658419 ID - Kautz2015 ER - TY - JOUR AU - Keerthivasan, G. AU - Wickrema, A. AU - Crispino, J. D. PY - 2011 DA - 2011// TI - Erythroblast enucleation JO - Stem Cells Int VL - 2011 UR - https://doi.org/10.4061/2011/139851 DO - 10.4061/2011/139851 ID - Keerthivasan2011 ER - TY - JOUR AU - Kohne, E. PY - 2011 DA - 2011// TI - Hemoglobinopathies: clinical manifestations, diagnosis, and treatment JO - Dtsch Arztebl Int VL - 108 ID - Kohne2011 ER - TY - JOUR AU - Koury, M. J. AU - Bondurant, M. C. PY - 1988 DA - 1988// TI - Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells JO - J Cell Physiol VL - 137 UR - https://doi.org/10.1002/jcp.1041370108 DO - 10.1002/jcp.1041370108 ID - Koury1988 ER - TY - JOUR AU - Kralovics, R. PY - 2005 DA - 2005// TI - A gain-of-function mutation of JAK2 in myeloproliferative disorders JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa051113 DO - 10.1056/NEJMoa051113 ID - Kralovics2005 ER - TY - JOUR AU - Kurtz, A. AU - Hartl, W. AU - Jelkmann, W. AU - Zapf, J. AU - Bauer, C. PY - 1985 DA - 1985// TI - Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I JO - J Clin Invest VL - 76 UR - https://doi.org/10.1172/JCI112149 DO - 10.1172/JCI112149 ID - Kurtz1985 ER - TY - JOUR AU - Kwiatkowski, J. L. PY - 2017 DA - 2017// TI - Clinical outcomes up to 3 years following Lentiglobin gene therapy for transfusion-dependent β-thalassemia in the Northstar Hgb-204 study JO - Blood VL - 130 UR - https://doi.org/10.1182/blood-2017-03-775767 DO - 10.1182/blood-2017-03-775767 ID - Kwiatkowski2017 ER - TY - JOUR AU - Landskron, G. AU - De la Fuente, M. AU - Thuwajit, P. AU - Thuwajit, C. AU - Hermoso, M. A. PY - 2014 DA - 2014// TI - Chronic inflammation and cytokines in the tumor microenvironment JO - J Immunol Res VL - 2014 UR - https://doi.org/10.1155/2014/149185 DO - 10.1155/2014/149185 ID - Landskron2014 ER - TY - JOUR AU - Langdon, J. M. PY - 2015 DA - 2015// TI - RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice JO - Am J Hematol VL - 90 UR - https://doi.org/10.1002/ajh.23856 DO - 10.1002/ajh.23856 ID - Langdon2015 ER - TY - JOUR AU - Lee, S. H. PY - 1988 DA - 1988// TI - Isolation and immunocytochemical characterization of human bone marrow stromal macrophages in hemopoietic clusters JO - J Exp Med VL - 168 UR - https://doi.org/10.1084/jem.168.3.1193 DO - 10.1084/jem.168.3.1193 ID - Lee1988 ER - TY - JOUR AU - Leikin, S. L. PY - 1989 DA - 1989// TI - Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease JO - Pediatrics VL - 84 ID - Leikin1989 ER - TY - JOUR AU - Leimberg, M. J. AU - Prus, E. AU - Konijn, A. M. AU - Fibach, E. PY - 2008 DA - 2008// TI - Macrophages function as a ferritin iron source for cultured human erythroid precursors JO - J Cell Biochem VL - 103 UR - https://doi.org/10.1002/jcb.21499 DO - 10.1002/jcb.21499 ID - Leimberg2008 ER - TY - JOUR AU - Leng, H. M. J. AU - Kidson, S. H. AU - Keraan, M. M. AU - Randall, G. W. AU - Folb, P. I. PY - 1996 DA - 1996// TI - Cytokine-mediated inhibition of erythropoietin synthesis by dexamethasone JO - J Pharm Pharmacol VL - 48 UR - https://doi.org/10.1111/j.2042-7158.1996.tb06015.x DO - 10.1111/j.2042-7158.1996.tb06015.x ID - Leng1996 ER - TY - JOUR AU - Ley, T. J. PY - 1982 DA - 1982// TI - 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia JO - N Engl J Med VL - 307 UR - https://doi.org/10.1056/NEJM198212093072401 DO - 10.1056/NEJM198212093072401 ID - Ley1982 ER - TY - JOUR AU - Ley, T. J. PY - 1983 DA - 1983// TI - 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia JO - Blood VL - 62 ID - Ley1983 ER - TY - JOUR AU - Libani, I. V. PY - 2008 DA - 2008// TI - Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2007-12-126938 DO - 10.1182/blood-2007-12-126938 ID - Libani2008 ER - TY - JOUR AU - Libregts, S. F. PY - 2011 DA - 2011// TI - Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2010-10-315218 DO - 10.1182/blood-2010-10-315218 ID - Libregts2011 ER - TY - JOUR AU - Lin, M. I. PY - 2017 DA - 2017// TI - CRISPR/Cas9 genome editing to treat sickle cell disease and B-thalassemia: re-creating genetic variants to upregulate fetal hemoglobin appear well-tolerated, effective and durable JO - Blood VL - 130 ID - Lin2017 ER - TY - JOUR AU - Liu, Y. PY - 2006 DA - 2006// TI - Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2005-11-4458 DO - 10.1182/blood-2005-11-4458 ID - Liu2006 ER - TY - JOUR AU - Locatelli, F. PY - 2004 DA - 2004// TI - Anemia management for hemodialysis patients: kidney disease outcomes quality initiative (K/DOQI) guidelines and dialysis outcomes and practice patterns study (DOPPS) findings JO - Am J Kidney Dis VL - 44 UR - https://doi.org/10.1016/S0272-6386(04)01102-3 DO - 10.1016/S0272-6386(04)01102-3 ID - Locatelli2004 ER - TY - JOUR AU - Lowrey, C. H. AU - Nienhuis, A. W. PY - 1993 DA - 1993// TI - Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309163291205 DO - 10.1056/NEJM199309163291205 ID - Lowrey1993 ER - TY - JOUR AU - Ludwiczek, S. AU - Aigner, E. AU - Theurl, I. AU - Weiss, G. PY - 2003 DA - 2003// TI - Cytokine-mediated regulation of iron transport in human monocytic cells JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-08-2459 DO - 10.1182/blood-2002-08-2459 ID - Ludwiczek2003 ER - TY - JOUR AU - Lux, C. PY - 2017 DA - 2017// TI - Talen mediated therapeutic gene editing strategy for ß-Hemoglobinopathies JO - Blood VL - 130 ID - Lux2017 ER - TY - JOUR AU - Ma, N. PY - 2013 DA - 2013// TI - Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells JO - J Biol Chem VL - 288 UR - https://doi.org/10.1074/jbc.M113.496174 DO - 10.1074/jbc.M113.496174 ID - Ma2013 ER - TY - JOUR AU - Maguer-Satta, V. PY - 2003 DA - 2003// TI - Regulation of human erythropoiesis by activin a, BMP2, and BMP4, members of the TGFbeta family JO - Exp Cell Res VL - 282 UR - https://doi.org/10.1016/S0014-4827(02)00013-7 DO - 10.1016/S0014-4827(02)00013-7 ID - Maguer-Satta2003 ER - TY - JOUR AU - Mansilla-Soto, J. AU - Riviere, I. AU - Boulad, F. AU - Sadelain, M. PY - 2016 DA - 2016// TI - Cell and gene therapy for the Beta-Thalassemias: advances and prospects JO - Hum Gene Ther VL - 27 UR - https://doi.org/10.1089/hum.2016.037 DO - 10.1089/hum.2016.037 ID - Mansilla-Soto2016 ER - TY - JOUR AU - Marktel, S. PY - 2017 DA - 2017// TI - Gene therapy for Beta thalassemia: preliminary results from the PHASE I/II Tiget-Bthal trial of autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector JO - Blood VL - 130 ID - Marktel2017 ER - TY - JOUR AU - Masera, N. PY - 2010 DA - 2010// TI - Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy JO - Blood Transfus VL - 8 ID - Masera2010 ER - TY - JOUR AU - May, C. PY - 2000 DA - 2000// TI - Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin JO - Nature VL - 406 UR - https://doi.org/10.1038/35017565 DO - 10.1038/35017565 ID - May2000 ER - TY - JOUR AU - Means, R. T. AU - Krantz, S. B. PY - 1993 DA - 1993// TI - Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon JO - J Clin Invest VL - 91 UR - https://doi.org/10.1172/JCI116216 DO - 10.1172/JCI116216 ID - Means1993 ER - TY - JOUR AU - Meiler, S. E. PY - 2011 DA - 2011// TI - Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2010-11-319137 DO - 10.1182/blood-2010-11-319137 ID - Meiler2011 ER - TY - JOUR AU - Mesa, R. PY - 2017 DA - 2017// TI - The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF) JO - Br J Haematol VL - 176 UR - https://doi.org/10.1111/bjh.14382 DO - 10.1111/bjh.14382 ID - Mesa2017 ER - TY - JOUR AU - Molokie, R. PY - 2017 DA - 2017// TI - Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: a randomized phase 1 study JO - PLoS Med VL - 14 UR - https://doi.org/10.1371/journal.pmed.1002382 DO - 10.1371/journal.pmed.1002382 ID - Molokie2017 ER - TY - JOUR AU - Moriguchi, T. AU - Yamamoto, M. PY - 2014 DA - 2014// TI - A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation JO - Int J Hematol VL - 100 UR - https://doi.org/10.1007/s12185-014-1568-0 DO - 10.1007/s12185-014-1568-0 ID - Moriguchi2014 ER - TY - JOUR AU - Moutouh-de Parseval, L. A. PY - 2008 DA - 2008// TI - Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells JO - J Clin Invest VL - 118 UR - https://doi.org/10.1172/JCI32322 DO - 10.1172/JCI32322 ID - Moutouh-de Parseval2008 ER - TY - JOUR AU - Musallam, K. M. PY - 2012 DA - 2012// TI - Fetal hemoglobin levels and morbidity in untransfused patients with beta-thalassemia intermedia JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-09-382408 DO - 10.1182/blood-2011-09-382408 ID - Musallam2012 ER - TY - JOUR AU - Nai, A. PY - 2012 DA - 2012// TI - Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2012-01-401885 DO - 10.1182/blood-2012-01-401885 ID - Nai2012 ER - TY - JOUR AU - Nemeth, E. PY - 2004 DA - 2004// TI - IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin JO - J Clin Invest VL - 113 UR - https://doi.org/10.1172/JCI200420945 DO - 10.1172/JCI200420945 ID - Nemeth2004 ER - TY - JOUR AU - Nemeth, E. PY - 2004 DA - 2004// TI - Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization JO - Science (New York, N.Y.) VL - 306 UR - https://doi.org/10.1126/science.1104742 DO - 10.1126/science.1104742 ID - Nemeth2004 ER - TY - STD TI - NCT02268409 (2018) ACE-536 extension study- beta thalassemia. ID - ref110 ER - TY - STD TI - NCT01571635 (2018) Study to evaluate the safety and tolerability of sotatercept (ACE-011) in adults with beta (B) thalassemia. ID - ref111 ER - TY - STD TI - NCT02604433 (2018) An efficacy and safety study of luspatercept (ACE-536) versus placebo in adults who require regular red blood cell transfusions due to beta (β) thalassemia (BELIEVE). Clinicaltrials.gov. 2017 Jan 19 [cited 2017 Oct 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT02604433?term=NCT02604433&rank=1. UR - https://clinicaltrials.gov/ct2/show/NCT02604433?term=NCT02604433&rank=1 ID - ref112 ER - TY - JOUR AU - Okam, M. M. PY - 2015 DA - 2015// TI - Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2015-03-635391 DO - 10.1182/blood-2015-03-635391 ID - Okam2015 ER - TY - JOUR AU - Olivieri, N. F. PY - 2011 DA - 2011// TI - A pilot study of subcutaneous decitabine in β-thalassemia intermedia JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-03-341909 DO - 10.1182/blood-2011-03-341909 ID - Olivieri2011 ER - TY - JOUR AU - Orkin, S. H. PY - 2000 DA - 2000// TI - Diversification of haematopoietic stem cells to specific lineages JO - Nat Rev Genet VL - 1 UR - https://doi.org/10.1038/35049577 DO - 10.1038/35049577 ID - Orkin2000 ER - TY - JOUR AU - Pace, B. S. PY - 2002 DA - 2002// TI - Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-02-0353 DO - 10.1182/blood-2002-02-0353 ID - Pace2002 ER - TY - JOUR AU - Palis, J. PY - 2014 DA - 2014// TI - Primitive and definitive erythropoiesis in mammals JO - Front Physiol VL - 5 UR - https://doi.org/10.3389/fphys.2014.00003 DO - 10.3389/fphys.2014.00003 ID - Palis2014 ER - TY - JOUR AU - Papadaki, H. A. AU - Kritikos, H. D. AU - Valatas, V. AU - Boumpas, D. T. AU - Eliopoulos, G. D. PY - 2002 DA - 2002// TI - Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-01-0136 DO - 10.1182/blood-2002-01-0136 ID - Papadaki2002 ER - TY - JOUR AU - Papanikolaou, G. PY - 2005 DA - 2005// TI - Hepcidin in iron overload disorders JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-12-4844 DO - 10.1182/blood-2004-12-4844 ID - Papanikolaou2005 ER - TY - JOUR AU - Passamonti, F. PY - 2003 DA - 2003// TI - Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia JO - Haematologica VL - 88 ID - Passamonti2003 ER - TY - JOUR AU - Pawliuk, R. PY - 2001 DA - 2001// TI - Correction of sickle cell disease in transgenic mouse models by gene therapy JO - Science (New York, NY) VL - 294 UR - https://doi.org/10.1126/science.1065806 DO - 10.1126/science.1065806 ID - Pawliuk2001 ER - TY - JOUR AU - Perrine, S. P. PY - 1993 DA - 1993// TI - A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders JO - N Engl J Med VL - 328 UR - https://doi.org/10.1056/NEJM199301143280202 DO - 10.1056/NEJM199301143280202 ID - Perrine1993 ER - TY - JOUR AU - Persons, D. A. AU - Hargrove, P. W. AU - Allay, E. R. AU - Hanawa, H. AU - Nienhuis, A. W. PY - 2003 DA - 2003// TI - The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-07-2211 DO - 10.1182/blood-2002-07-2211 ID - Persons2003 ER - TY - JOUR AU - Persons, D. A. PY - 2001 DA - 2001// TI - Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy JO - Blood VL - 97 UR - https://doi.org/10.1182/blood.V97.10.3275 DO - 10.1182/blood.V97.10.3275 ID - Persons2001 ER - TY - JOUR AU - Perumbeti, A. PY - 2009 DA - 2009// TI - A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-01-201863 DO - 10.1182/blood-2009-01-201863 ID - Perumbeti2009 ER - TY - JOUR AU - Pestina, T. I. PY - 2009 DA - 2009// TI - Correction of murine sickle cell disease using γ-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin JO - Mol Ther VL - 17 UR - https://doi.org/10.1038/mt.2008.259 DO - 10.1038/mt.2008.259 ID - Pestina2009 ER - TY - JOUR AU - Piel, F. B. AU - Steinberg, M. H. AU - Rees, D. C. PY - 2017 DA - 2017// TI - Sickle cell disease JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMra1510865 DO - 10.1056/NEJMra1510865 ID - Piel2017 ER - TY - JOUR AU - Piga, A. G. T. I. AU - Gamberini, R. PY - 2016 DA - 2016// TI - Luspatercept increases hemoglobin, decreases transfusion burden and improves iron overload in adults with beta-thalassemia JO - Blood VL - 128 ID - Piga2016 ER - TY - JOUR AU - Platt, O. S. PY - 1994 DA - 1994// TI - Mortality in sickle cell disease -- life expectancy and risk factors for early death JO - N Engl J Med VL - 330 UR - https://doi.org/10.1056/NEJM199406093302303 DO - 10.1056/NEJM199406093302303 ID - Platt1994 ER - TY - JOUR AU - Pontikoglou, C. PY - 2006 DA - 2006// TI - Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia JO - Exp Hematol VL - 34 UR - https://doi.org/10.1016/j.exphem.2006.05.010 DO - 10.1016/j.exphem.2006.05.010 ID - Pontikoglou2006 ER - TY - BOOK AU - Porpiglia, E. PY - 2012 DA - 2012// TI - Stat5 signaling specifies basal versus stress Erythropoietic ID - Porpiglia2012 ER - TY - JOUR AU - Powars, D. R. AU - Chan, L. AU - Schroeder, W. A. PY - 1989 DA - 1989// TI - The influence of fetal hemoglobin on the clinical expression of sickle cell anemia JO - Ann N Y Acad Sci VL - 565 UR - https://doi.org/10.1111/j.1749-6632.1989.tb24174.x DO - 10.1111/j.1749-6632.1989.tb24174.x ID - Powars1989 ER - TY - JOUR AU - Powars, D. R. AU - Chan, L. S. AU - Hiti, A. AU - Ramicone, E. AU - Johnson, C. PY - 2005 DA - 2005// TI - Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients JO - Medicine VL - 84 UR - https://doi.org/10.1097/01.md.0000189089.45003.52 DO - 10.1097/01.md.0000189089.45003.52 ID - Powars2005 ER - TY - JOUR AU - Raza, A. PY - 2008 DA - 2008// TI - Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-01-068833 DO - 10.1182/blood-2007-01-068833 ID - Raza2008 ER - TY - JOUR AU - Reid, M. E. PY - 2014 DA - 2014// TI - A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease JO - Am J Hematol VL - 89 UR - https://doi.org/10.1002/ajh.23725 DO - 10.1002/ajh.23725 ID - Reid2014 ER - TY - JOUR AU - Ribeil, J. A. PY - 2017 DA - 2017// TI - Gene therapy in a patient with sickle cell disease JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1609677 DO - 10.1056/NEJMoa1609677 ID - Ribeil2017 ER - TY - JOUR AU - Rivella, S. PY - 2009 DA - 2009// TI - Ineffective erythropoiesis and thalassemias JO - Curr Opin Hematol VL - 16 UR - https://doi.org/10.1097/MOH.0b013e32832990a4 DO - 10.1097/MOH.0b013e32832990a4 ID - Rivella2009 ER - TY - JOUR AU - Rosanwo, T. O. AU - Kinney, M. AU - Vo, L. T. AU - Lundin, V. AU - Daley, G. Q. PY - 2017 DA - 2017// TI - Enucleation and Beta-globin expression in induced red blood cells: a platform to model sickle cell anemia JO - Blood VL - 130 ID - Rosanwo2017 ER - TY - JOUR AU - Sawada, K. AU - Krantz, S. B. AU - Dessypris, E. N. AU - Koury, S. T. AU - Sawyer, S. T. PY - 1989 DA - 1989// TI - Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development JO - J Clin Invest VL - 83 UR - https://doi.org/10.1172/JCI114070 DO - 10.1172/JCI114070 ID - Sawada1989 ER - TY - JOUR AU - Schmidt, P. J. PY - 2013 DA - 2013// TI - An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(−/−) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-09-453977 DO - 10.1182/blood-2012-09-453977 ID - Schmidt2013 ER - TY - JOUR AU - Schmidt, P. J. PY - 2015 DA - 2015// TI - Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia JO - Am J Hematol VL - 90 UR - https://doi.org/10.1002/ajh.23934 DO - 10.1002/ajh.23934 ID - Schmidt2015 ER - TY - JOUR AU - Sebastiano, V. PY - 2011 DA - 2011// TI - In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases JO - Stem cells (Dayton, Ohio) VL - 29 UR - https://doi.org/10.1002/stem.718 DO - 10.1002/stem.718 ID - Sebastiano2011 ER - TY - JOUR AU - Seki, M. AU - Shirasawa, H. PY - 1965 DA - 1965// TI - Role of the reticular cells during maturation process of the erythroblast. 3. The fate of phagocytized nucleus JO - Acta Pathol Jpn VL - 15 ID - Seki1965 ER - TY - JOUR AU - Shearstone, J. R. PY - 2016 DA - 2016// TI - Chemical inhibition of histone deacetylases 1 and 2 induces fetal hemoglobin through activation of GATA2 JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0153767 DO - 10.1371/journal.pone.0153767 ID - Shearstone2016 ER - TY - JOUR AU - Skov, V. PY - 2012 DA - 2012// TI - Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms JO - Leuk Lymphoma VL - 53 UR - https://doi.org/10.3109/10428194.2011.597905 DO - 10.3109/10428194.2011.597905 ID - Skov2012 ER - TY - JOUR AU - Skutelsky, E. AU - Danon, D. PY - 1972 DA - 1972// TI - On the expulsion of the erythroid nucleus and its phagocytosis JO - Anat Rec VL - 173 UR - https://doi.org/10.1002/ar.1091730111 DO - 10.1002/ar.1091730111 ID - Skutelsky1972 ER - TY - JOUR AU - Sun, N. AU - Zhao, H. PY - 2014 DA - 2014// TI - Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs JO - Biotechnol Bioeng VL - 111 UR - https://doi.org/10.1002/bit.25018 DO - 10.1002/bit.25018 ID - Sun2014 ER - TY - JOUR AU - Sunshine, H. R. AU - Hofrichter, J. AU - Eaton, W. A. PY - 1978 DA - 1978// TI - Requirement for therapeutic inhibition of sickle haemoglobin gelation JO - Nature VL - 275 UR - https://doi.org/10.1038/275238a0 DO - 10.1038/275238a0 ID - Sunshine1978 ER - TY - JOUR AU - Suragani, R. N. PY - 2014 DA - 2014// TI - Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis JO - Nat Med VL - 20 UR - https://doi.org/10.1038/nm.3512 DO - 10.1038/nm.3512 ID - Suragani2014 ER - TY - JOUR AU - Suragani, R. N. PY - 2014 DA - 2014// TI - Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine beta-thalassemia JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-06-511238 DO - 10.1182/blood-2013-06-511238 ID - Suragani2014 ER - TY - JOUR AU - Swerdlow, P. S. PY - 2013 DA - 2013// TI - Pomalidomide in sickle cell disease: phase I study of a novel anti-switching agent JO - Blood VL - 122 ID - Swerdlow2013 ER - TY - JOUR AU - Taniguchi, S. AU - Dai, C. H. AU - Price, J. O. AU - Krantz, S. B. PY - 1997 DA - 1997// TI - Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells JO - Blood VL - 90 ID - Taniguchi1997 ER - TY - JOUR AU - Tefferi, A. PY - 2009 DA - 2009// TI - Pomalidomide is active in the treatment of anemia associated with myelofibrosis JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.7356 DO - 10.1200/JCO.2008.21.7356 ID - Tefferi2009 ER - TY - JOUR AU - Tefferi, A. PY - 2013 DA - 2013// TI - Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2013.163 DO - 10.1038/leu.2013.163 ID - Tefferi2013 ER - TY - STD TI - Valdés-Ferrer SI, et al. HMGB1 mediates anemia of inflammation in murine sepsis survivors. Mol Med. 2015. https://doi.org/10.2119/molmed.2015.00243. PMCID: PMC4818261. ID - ref155 ER - TY - JOUR AU - Vannucchi, A. M. PY - 2015 DA - 2015// TI - Ruxolitinib versus standard therapy for the treatment of polycythemia Vera JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1409002 DO - 10.1056/NEJMoa1409002 ID - Vannucchi2015 ER - TY - JOUR AU - Verstovsek, S. PY - 2017 DA - 2017// TI - Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0417-z DO - 10.1186/s13045-017-0417-z ID - Verstovsek2017 ER - TY - CHAP AU - Vijay, G. AU - Sankaran, D. G. N. AU - Orkin, S. H. AU - Look, A. T. ED - Orkin, S. H. ED - Fisher, D. E. ED - Ginsburg, D. ED - Lux, S. E. ED - Nathan, D. G. PY - 2015 DA - 2015// TI - Thalassemias BT - Nathan and Oski's hematology and oncology of infancy and childhood PB - Elsevier CY - Philadelphia ID - Vijay2015 ER - TY - JOUR AU - Wang, C. Q. AU - Udupa, K. B. AU - Lipschitz, D. A. PY - 1995 DA - 1995// TI - Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development JO - J Cell Physiol VL - 162 UR - https://doi.org/10.1002/jcp.1041620116 DO - 10.1002/jcp.1041620116 ID - Wang1995 ER - TY - JOUR AU - Ware, R. E. AU - de Montalembert, M. AU - Tshilolo, L. AU - Abboud, M. R. PY - 2017 DA - 2017// TI - Sickle cell disease JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)30193-9 DO - 10.1016/S0140-6736(17)30193-9 ID - Ware2017 ER - TY - STD TI - Weatherall D, Akinyanju O, Fucharoen S, et al. Inherited disorders of hemoglobin. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development / the World Bank; 2006. Chapter 34. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11727/ Co-published by Oxford University Press, New York. In.. UR - https://www.ncbi.nlm.nih.gov/books/NBK11727 ID - ref161 ER - TY - JOUR AU - Weinstein, D. A. PY - 2002 DA - 2002// TI - Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-04-1260 DO - 10.1182/blood-2002-04-1260 ID - Weinstein2002 ER - TY - JOUR AU - Witthuhn, B. A. PY - 1993 DA - 1993// TI - JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin JO - Cell VL - 74 UR - https://doi.org/10.1016/0092-8674(93)90414-L DO - 10.1016/0092-8674(93)90414-L ID - Witthuhn1993 ER - TY - JOUR AU - Wrighting, D. M. AU - Andrews, N. C. PY - 2006 DA - 2006// TI - Interleukin-6 induces hepcidin expression through STAT3 JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2006-06-027631 DO - 10.1182/blood-2006-06-027631 ID - Wrighting2006 ER - TY - JOUR AU - Wu, H. AU - Liu, X. AU - Jaenisch, R. AU - Lodish, H. F. PY - 1995 DA - 1995// TI - Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor JO - Cell VL - 83 UR - https://doi.org/10.1016/0092-8674(95)90234-1 DO - 10.1016/0092-8674(95)90234-1 ID - Wu1995 ER - TY - JOUR AU - Xu, P. PY - 2015 DA - 2015// TI - Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in beta-thalassemia-derived iPSCs JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep12065 DO - 10.1038/srep12065 ID - Xu2015 ER - TY - JOUR AU - Yan, D. AU - Hutchison, R. E. AU - Mohi, G. PY - 2012 DA - 2012// TI - Critical requirement for Stat5 in a mouse model of polycythemia vera JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-03-345215 DO - 10.1182/blood-2011-03-345215 ID - Yan2012 ER - TY - JOUR AU - Yu, V. W. C. PY - 2017 DA - 2017// TI - CRISPR/Cas9 gene-edited hematopoietic stem cell therapy for sickle cell disease JO - Blood VL - 130 ID - Yu2017 ER - TY - JOUR AU - Yuan, J. AU - Rubin, E. AU - Aljurf, M. AU - Ma, L. AU - Schrier, S. L. PY - 1994 DA - 1994// TI - Defective assembly of membrane proteins in erythroid precursors of beta-thalassemic mice JO - Blood VL - 84 ID - Yuan1994 ER - TY - JOUR AU - Zhang, Y. PY - 2014 DA - 2014// TI - Erythropoietin action in stress response, tissue maintenance and metabolism JO - Int J Mol Sci VL - 15 UR - https://doi.org/10.3390/ijms150610296 DO - 10.3390/ijms150610296 ID - Zhang2014 ER - TY - JOUR AU - Zhou, D. AU - Liu, K. AU - Sun, C. W. AU - Pawlik, K. M. AU - Townes, T. M. PY - 2010 DA - 2010// TI - KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching JO - Nat Genet VL - 42 UR - https://doi.org/10.1038/ng.637 DO - 10.1038/ng.637 ID - Zhou2010 ER -